baber/WOPTO huggingface dataset:
Patent AU-2019345878-A1 (AU)
Title: Monolithic glass ring and method for optical current measurements
Inventor: SCHUBERTH STEFAN
IPC: G01R15/24
Filed: 2019-09-06
Abstract: The invention relates to a glass ring (1) for current measurements, comprising a glass body, which can be arranged around an electrical conductor (2) and has a light entry surface (4) and a light exit surface (5). The glass ring (1) is designed to allow light which enters the glass body through the light entry surface (4) to circulate completely around the conductor (2) in the glass body by reflection on outer faces of the glass body, the light exiting from the glass body on the light exit surface (5). The glass ring (1) consists of a monolithic glass body. The method according to the invention for optical current measurement comprises a current flow (3) in an electrical conductor (2) generating an electromagnetic field around the conductor (2), by means of which the polarisation of a light beam in the glass ring (1), which is arranged around the conductor (2), in particular with a plane perpendicular to the longitudinal axis of the conductor, is changed as the light beam circulates around the conductor (2).
Patent AU-2019360630-A1 (AU)
Title: Method for obtaining crystalline 2'-fucosyllactose
Inventor: PUHL MICHAEL
IPC: C07H1/06
Filed: 2019-10-17
Abstract: The present invention relates to a method for obtaining crystalline 2'-fucosyllactose from a 2'-FL raw material, which contains 2'-FL as a main constituent and at least 0.5% by weight, frequently at least 1% by weight, in particular at least 2% by weight, more particularly at least 5% by weight, and especially at least 8% by weight,based on the total amount of mono-and oligosaccharides in the raw material, of one or more mono- or oligosaccharides different from 2'-FL, where the method comprises a)providing a solution of the 2'-FL raw material in water, which does not contain more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents, based on the total amount of water; b) effecting the crystallization of 2'-FL from the solution provided in step a) by inducing conditions of a controlled super saturation in the solution; and c) separating crystalline 2'-FL from the mother liquor, and where during controlled supersaturation in step b) not more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents are present, based on the total amount of water present during step b).
Patent AU-2019392906-A1 (AU)
Title: Systems for protein-protein interaction screening
Inventor: CHAN HENRY
IPC: C40B30/04
Filed: 2019-12-06
Abstract: Described herein are methods and systems useful for interrogating protein-protein interactions. These systems utilize non-functional fragments of polypeptides that can complement each other to form a fully functional fragment
Patent AU-2019394940-A1 (AU)
Title: Diagnostic methods and compositions for cancer immunotherapy
Inventor: WU THOMAS D
IPC: C07K16/30
Filed: 2019-12-04
Abstract: The present invention provides diagnostic methods, therapeutic methods, and compositions for the treatment of cancer. The compositions and methods described herein can be used, for example, to determine the propensity of a patient to benefit from treatment with a PD-L1 axis binding antagonist and to treat such patients accordingly. Using the compositions and methods of the disclosure, a patient, such as a human cancer patient, may be determined to be likely to benefit from treatment with a PD-L1 axis binding antagonist if the patient exhibits an elevated pre-treatment expression level of one or more of CST7, NKG7, GZMH, MT-ND4, HLA-H, CCL5, CD8A, CMC1, CD8B, HCST, MT-CYB, MT-ND4L, KLRG1, MT-CO2, MT-ATP6, PLEK, CTSW, HLA-C, LYAR, LITAF, GZMB, KLRD1, FGFBP2, KLRC4-KLRK1, KLRK1, B2M, GZMA, ID2, CX3CR1, PRSS23, GNLY, PRF1, and PATL2. Exemplary PD-L1 axis binding antagonists that may be used in conjunction with the compositions and methods of the disclosure are PD-L1 binding antagonists, such as anti-PD-L1 antibodies and antigen-binding fragments thereof, including atezolizumab, as well as PD-1 binding antagonists, such as anti-PD-1 antibodies and antigen-binding fragments thereof.
Patent AU-2019414460-A1 (AU)
Title: A video encoder, a video decoder and corresponding methods
Inventor: WANG YE-KUI
IPC: H04N19/46
Filed: 2019-12-27
Abstract: A video coding mechanism is disclosed. The mechanism includes partitioning a picture into a plurality of first level tiles. A subset of the first level tiles is partitioned into a plurality of second level tiles. Each second level tile contains a single rectangular slice of picture data. The first level tiles and the second level tiles are encoded into a bitstream. The bitstream is stored for communication toward a decoder.
Patent AU-2019425173-A1 (AU)
Title: Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
Inventor: BRUUN HEIDI ZIEGLER
IPC: A23L33/105
Filed: 2019-10-10
Abstract: The present invention relates to a chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum comprising water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8- 50% by weight of the gum base, and wherein the one or more elastomer plasticizers comprise one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base, and wherein the chewing gum comprises one or more cannabinoids.
Patent AU-2020200095-A1 (AU)
Title: Portable sun-shade assembly
Inventor: SMITH JOEL GEOFFREY
IPC: E04H15/54
Filed: 2020-01-07
Abstract: A portable sunshade assembly comprising: an in-use top flexible sheet spaced away 
from an in-use bottom flexible sheet wherein during use in an extended configuration 
the top and bottom flexible sheets comprise respective surfaces and are arranged to 
define a space there-between to provide a plurality of passages located between the 
first and second sheets to allow air to pass in a direction from a first side of the top 
and bottom flexible sheets to a second side of the top and bottom flexible sheets.
117 
CN 
ICV) 
CC% 
SC 
f LO (q 
U') 
III 
~ IO 
IIO 
CYI 
I CI 
I 04 
CDN
Patent AU-2020202461-A1 (AU)
Title: Distributing payment keys among multiple discrete devices in a point of sale system
Inventor: MURRAY BRIAN JEREMIAH
IPC: H04L9/14
Filed: 2020-04-09
Abstract: DISTRIBUTING PAYMENT KEYS AMONG MULTIPLE DISCRETE DEVICES IN A POINT OF SALE SYSTEM Methods and systems related to distributing payment keys to multiple discrete devices in a point of sale (POS) system (100) are disclosed. One method includes storing a payment key on a first discrete device for a POS system (100) and a public key certificate on a second discrete device for the POS system (100). The method also includes communicatively connecting the first discrete device with the second discrete device using a wire, transmitting the public key certificate from the second discrete device to the first discrete device using the wire, and verifying the public key certificate on the first discrete device. The method also includes finalizing a secure connection between the first discrete device and the second discrete device over the wire using a transport layer secure (TLS) protocol after the public key certificate is verified.
Patent AU-2020209768-A1 (AU)
Title: Augmented cognition methods and apparatus for contemporaneous feedback in psychomotor learning
Inventor: YANG SHANE
IPC: G06T11/00
Filed: 2020-01-15
Abstract: A method of creating a scalable dynamic jointed skeleton (DJS) model for enhancing psychomotor leaning using augmented cognition methods realized by an artificial intelligence (AI) engine or image processor. The method involves extracting a DJS model from either live motion images of video files of an athlete, teacher, or expert to create a scalable reference model for using in training, whereby the AI engine extracts physical attributes of the subject including arm length, length, torso length as well as capturing successive movements of a motor skill such as swinging a gold club including position, stance, club position, swing velocity and acceleration, twisting, and more.
Patent AU-2020220225-A1 (AU)
Title: Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
Inventor: ROWBOTTOM MARTIN W
IPC: A61K31/4439
Filed: 2020-08-24
Abstract: Described herein are compounds that are LOXL2 inhibitors, methods of making such 
compounds, pharmaceutical compositions and medicaments comprising such compounds, and 
methods of using such compounds in the treatment of conditions, diseases, or disorders 
associated with LOXL2 activity.
Patent AU-2020221367-A1 (AU)
Title: Portable electrical stimulation system and method
Inventor: ZOBKIW CHRIS
IPC: A61N1/36
Filed: 2020-02-13
Abstract: The present disclosure is directed to a portable system and method for modulating targeted neural and non-neural tissue of a nervous system to block nerve conduction for the treatment of pain, A high-efficiency portable electrical stimulation system is provided that allows a user to carry the system and move around freely while continuously receiving therapy. The electronic control system is configured to deliver high-frequency electrical stimulation at a therapeutic level, for an intended duration (e.g., up to 24 hours or more) at a manageable and/or comfortable weight for a person, to the target nerve.
Patent AU-2020223667-A1 (AU)
Title: Extensible analytics and recommendation engine for network traffic data
Inventor: VERES GREG
IPC: H04L12/24
Filed: 2020-08-25
Abstract: A method of analyzing data on network traffic in a network having a plurality of computing 
devices coupled to a network traffic appliance that routes data to and from the computing devices, 
the method comprising: installing a plug-in network traffic analysis module on a network traffic 
recommendation engine running the network traffic analysis module to obtain selected network 
traffic data on the network; analyzing the selected network traffic data via the network traffic 
analysis module; outputting a recommendation based on the selected network traffic data; and 
adjusting a policy based on the recommendation to improve the efficiency of the sending and 
receiving of network traffic to the plurality of computing devices.
Patent AU-2020232257-A1 (AU)
Title: Heat transfer compositions comprising R-1225ye(E)
Inventor: MINOR BARBARA HAVILAND
IPC: C09K5/04
Filed: 2020-03-03
Abstract: The present application relates to compositions comprising (E)-1,2,3,3,3-pentafluoro-1-propene (i.e., R-1225ye(E) or HFO-1225ye(E)) that are useful in refrigeration, air conditioning, or heat pump systems. Methods of replacing R-1234ze(E) in refrigeration, air conditioning, or heat pump systems are also provided.
Patent AU-2020241258-A1 (AU)
Title: Novel small molecule inhibitors of tead transcription factors
Inventor: MAITI PRANAB
IPC: A61K31/5377
Filed: 2020-03-13
Abstract: The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.
Patent AU-2020262767-A1 (AU)
Title: Dental Restorative Curable Composition
Inventor: ICHIKAWA Seiya
IPC: A61K6/887
Filed: 2020-04-23
Abstract: The present invention provides a curable composition for dental restoration, a cured product of which has high mechanical strength and excellent water resistance and polishability; a dental composite resin comprising the curable composition for dental restoration; and a dental mill blank comprising a cured product of the curable composition for dental restoration. The present invention relates to a curable composition for dental restoration that contains a (meth)acrylic acid ester compound (A) having two or more (meth)acryloyloxy groups per molecule, a mono(meth)acrylic acid ester compound (B), an inorganic filler (C) having an average primary particle size of 0.01-5 μm, and a polymerization initiator (D). The mono(meth)acrylic acid ester compound includes at least one selected from the group consisting of mono(meth)acrylic acid ester compounds (B-1) represented by general formula (I) and mono(meth)acrylic acid ester compounds (B)-2) represented by general formula (II).
Patent AU-2020290781-A1 (AU)
Title: Hybrid metal ceramic ball valve
Inventor: THOMPSON STEPHEN
IPC: F16K25/00
Filed: 2020-06-05
Abstract: A ball valve for controlling the flow of a fluid comprising a housing (1) comprised of a metallic material; said housing comprising an inlet and an outlet of a fluid passageway (7) extending therethrough; an actuation mechanism for moving the ball valve housing (1) from an open position to a closed position; a valve seat (9) for sealing the inlet from leakage of the fluid; wherein the ball valve further comprises a sealing dome comprising a ceramic sealing face (2) adapted to circumferentially seal against the valve seat (9) when the ball valve is in the closed position and a metal cap (4).
Patent AU-2020315459-A1 (AU)
Title: Clostridia consortia compositions and methods of treating obesity, metabolic syndrome and irritable bowel disease
Inventor: ROUND JUNE L
IPC: A61K9/00
Filed: 2020-07-17
Abstract: Disclosed herein, are compositions comprising a consortium of Clostridia, and methods of treating obesity, metabolic syndrome, irritable bowel disease, as well as reducing weight gain and inhibiting lipid absorption in the small intestine by administering the compositions to a subject.
Patent AU-2020327153-A1 (AU)
Title: Adhesive penile construction template and urethra scaffold tube for neophallus surgery
Inventor: FELTON JESSICA ELIZABETH
IPC: A61B17/322
Filed: 2020-07-30
Abstract: A penile construction template (100) includes an adhesive film (102) configured for adhesion to donor skin. The penile construction template includes a first section (106) defined on the adhesive film to identify an external phallus skin flap of the donor skin to be extracted while the adhesive film is adhered to the donor skin, and a second section (108) defined on the adhesive film to identify a de- epithelialized skin flap of the donor skin to be extracted while the adhesive film is adhered to the donor skin. An implantable device for urethra construction includes a tubular scaffold (500) configured to be coupled to a natal urethra of a patient, the tubular scaffold being seeded with urethral cells of the patient for growth of a urethral segment on the tubular scaffold therefrom while disposed within a body of the patient.
Patent AU-2020335023-A1 (AU)
Title: An interdental cleaning device
Inventor: WEBBER JAMIE
IPC: A46B15/00
Filed: 2020-08-24
Abstract: An interdental cleaning device includes a handle. A cleaning head assembly is mounted on the handle. The cleaning head assembly includes a head that is mounted on the handle, the head defining a cavity. An interdental cleaning member is mounted on the head to extend into the cavity, the interdental cleaning member including an interdental cleaning element. A plunger is mounted on the head, the plunger being reciprocally displaceable relative to the head between an operative position in which the plunger is at least partially retracted into the cavity and an inoperative position in which the plunger extends from the cavity. A spring mechanism is interposed between the plunger and the head so that the movement of the plunger into the operative position is against a bias of the spring mechanism. The plunger defines a longitudinally extending passage that is dimensioned to accommodate the cleaning element. The interdental cleaning member is positioned so that the interdental cleaning element extends from a distal opening of the longitudinal passage when the plunger is in the operative position and is positioned within the plunger when the plunger is in the inoperative position.
Patent AU-2020342483-A1 (AU)
Title: Lurbinectedin in the treatment of malignant mesothelioma
Inventor: METAXAS IOANNIS
IPC: A61K31/4995
Filed: 2020-09-03
Abstract: The use of Lurbinectedin in the treatment of malignant mesothelioma is provided.
Patent AU-2020364335-A1 (AU)
Title: Medical device comprising an articulation joint between a first transducer and a second transducer and an apparatus and storage for its realization
Inventor: DAYTON PETER L
IPC: A61B8/08
Filed: 2020-09-30
Abstract: A medical device comprises a flexible elongate member (304), a first transducer (310-1), a second transducer (310-2) and an articulation joint (312) disposed along the distal portion of the flexible elongate member between the first transducer and the second transducer. The device may be used to generate images with a plurality of imaging techniques to localize anatomic features and/or components of a flexible elongate member for one or more of inspection, orientation and facilitating access to body passageways or lumens.
Patent AU-2020366019-A1 (AU)
Title: Behaviors that reduce demand on autonomous follower vehicles
Inventor: GEORGE MICHAEL DAVID
IPC: B60W30/165
Filed: 2020-10-15
Abstract: Methods and apparatus that reduce demands on behavior of autonomous vehicles operating in a convoy, such as lane following or leader swap.
Patent AU-2020399975-A1 (AU)
Title: Methods for treating digitally-identified IL-4/IL-13 related disorders
Inventor: MOLONY CLIONA MARIE
IPC: A61P37/00
Filed: 2020-12-08
Abstract: Disclosed are methods of treating various disorders with anti-IL-4Rα antibodies and fragments thereof.
Patent AU-2020407645-A1 (AU)
Title: Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same
Inventor: BASSAGANYA-RIERA JOSEP
IPC: A61P31/00
Filed: 2020-12-18
Abstract: Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including autoimmune diseases, inflammatory diseases, chronic inflammatory diseases, diabetes, and infectious diseases, such as lupus, rheumatoid arthritis, type 1 diabetes, inflammatory bowel disease, viral diseases, and nonalcoholic steatohepatitis. The compounds can also be used to generate cells, such as immune cells, for treating the conditions.
Patent AU-2020409674-A1 (AU)
Title: Volumetric video with auxiliary patches
Inventor: DORE RENAUD
IPC: G06T15/08
Filed: 2020-12-17
Abstract: Methods and devices for encoding and decoding data representative of a 3D scene are disclosed. A set of first patches is generated from a first MVD content acquired from a first region of the 3D scene. A patch is a part of one of the views of the MVD content. A set of second patches is generated from a second MVD content acquired from a second region of the 3D scene. An atlas packing first and second patches is generated and associated with metadata indicating, for a patch of the atlas, whether the patch is a first or a second patch At the decoding side, first patches are used for rendering the viewport image and second patches are used for pre-processing or post-processing the viewport image.
Patent AU-2020415322-A1 (AU)
Title: Pharmaceutical combination of antiviral agents targeting HBV and/or an immune modulator for treatment of HBV
Inventor: OTTOSEN SØREN
IPC: A61K31/554
Filed: 2020-12-22
Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of certain antiviral compounds and immune modulator compounds.
Patent AU-2020418449-A1 (AU)
Title: Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (reCG), the recombinant cell lines producing reCG, large-scale reCG production method, reCG, formulations containing reCG, nucleic acids encoding for reCG and uses
Inventor: CEAGLIO NATALIA
IPC: C12N15/867
Filed: 2020-12-23
Abstract: The present invention describes a method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (reCG) hormone. A cell line expressing reCG, a large-scale method for producing reCG, a reCG with a higher biological activity regarding PMSG, formulations containing reCG, nucleic acids encoding reCG and uses are also described.
Patent AU-2020438051-A1 (AU)
Title: Resource operation planning assistance apparatus and resource operation planning assistance method
Inventor: YAMASHITA YUKO
IPC: G06Q50/30
Filed: 2020-09-03
Abstract: Provided is a resource management plan assistance device that automatically generates a change tendency from a past resource management plan change history, uses the change tendency to generate a proposal to eliminate inconsistencies in the resource management plan, and presents the proposal in priority order.　The invention comprises: a route candidate creation unit that creates route candidates for each resource; a history learning unit that, in advance, learns a management plan history to generate a route change rule; a route candidate list creation unit that creates a list of route candidates for a management plan target resource; a plan creation unit that creates a management plan which, for one or more violations included in a management plan, eliminates the violation; and a management change content display unit. The route change rule created in advance by the history learning unit is applied to the route candidates created by the route candidate creation unit to calculate an adoption rate of each route candidate; and the route candidate list created by the route candidate list creation unit for each resource is used as input by the management change content display unit to display the management plan created by the plan creation unit in priority order.
Patent AU-2021200105-A1 (AU)
Title: Anomalous neutral electrical protection apparatus
Inventor: ROSEWARNE KARL ROBERT
IPC: G01R31/52
Filed: 2021-01-08
Abstract: Provided is an anomalous neutral electrical protection breaker 
10 comprising a DIN-mountable housing 30 for mounting as part 
of an electrical distribution board of an electrical 
installation 8, a neutral connector 14 for interconnecting to 
a neutral connection 12 of the electrical installation 8, and 
a live connector 18 for interconnecting to a live mains 
electrical supply 16 of the electrical installation 8. Breaker 
10 also includes an actuator 20 configured to selectively 
interrupt the live connector 18 interconnect to interrupt the 
mains electrical supply 22, and microprocessor 24 configured 
to induce a time-domain reflectometry signal onto the neutral 
connection 12, to monitor the neutral connection for 
reflections of the induced signal, to correlate the induced 
and reflected signals to determine if such correlation 
satisfies a predetermined criterion indicative of a neutral 
anomaly, and if the criterion is indicative of an anomaly, to 
activate the actuator 20 to interrupt the mains electricity 
supply 22.
3/3 
40 
SSTDR Injection 
4 2 
Supply Neutral Monitoring 
4 44 
Supply Neutral Test Value 
46 Analysis - Microprocessor 
50 
5 2 YES is Anomaly Present? NO 
Inductive Mechanical Coil 5 4 
4 8 
Mechanical Contactor Set56 
Open Circuited 
Supply Feed to Installation 5 8 
Broken 
Figure 3 .